Ade Adamson, MD MPP

17K posts

Ade Adamson, MD MPP banner
Ade Adamson, MD MPP

Ade Adamson, MD MPP

@AdeAdamson

Dermatologist | Health Services Researcher | Alum: @Morehouse @HarvardMed @MIT_HST @Kennedy_School | A naive EBM aficionado| Cancer researcher | Melanoma expert

Austin, TX Katılım Mart 2015
895 Takip Edilen7.7K Takipçiler
Ade Adamson, MD MPP retweetledi
Lior Pachter
Lior Pachter@lpachter·
This person has published 71 papers in 143 days so far in 2026. That is, 2 days per paper (source: Google Scholar). It's truly amazing. To see someone proud of this.
Liang Cheng, MD@LiangChengMD

I am deeply humbled and grateful to learn that my H-index has now reached 140. I was also honored to see that I am currently ranked among the two most-cited researchers worldwide in the fields of Urologic Oncology and Urology on Google Scholar.   In addition, my i10-index has reached 1060; that is, one thousand and sixty publications each cited at least ten times. I was told that this may represent a world record – what an extraordinary honor!   Nonetheless, these numbers are far less important than the people, mentorship, friendships, and collaborations behind them. This milestone is truly a triumph of team science. I owe immense gratitude to my mentors, colleagues, collaborators, residents, fellows, medical students, and friends who have inspired and supported me throughout this journey over the past two decades.   Academic medicine is never an individual accomplishment. It is ultimately about advancing science and medicine, educating future generations, and improving patient care. If our work has contributed even in a small way toward those goals, then I feel extraordinarily fortunate and grateful.   Thank you for being part of this journey. The best is yet to come!

English
104
260
3.5K
778.1K
Ade Adamson, MD MPP retweetledi
Healio
Healio@GoHealio·
🩴Summer is coming! Before you start spending more time in the sun, make sure you're applying sunscreen correctly to protect your skin. @DrJoelGelfand talks with @AdeAdamson about: 🧴How much sunscreen to use 🧴How soon to apply and reapply 🧴And more! healio.com/news/dermatolo…
English
0
2
6
192
Joseph Younis, MD
Joseph Younis, MD@YounisJoseph·
@AdeAdamson Stop. You’re about to motivate them to automate punch biopsies and wide excisions
English
1
0
1
43
Ade Adamson, MD MPP
Ade Adamson, MD MPP@AdeAdamson·
Its wild how much attention this has received. This technology already exists (has for many years) and in the only RCT looking at effectiveness in melanoma screening it did not improve outcomes in high risk people: jamanetwork.com/journals/jamad… Cool looking robot though...
Ritwik Pavan@ritwikpavan

JUST IN: Skin exams are getting automated. SquareMind just raised $18M to build a robotic system that scans your entire body and tracks every mole over time. • Swan robot captures full-body dermoscopic images in minutes • Tracks new and changing spots across visits • Replaces spot-check exams with total skin coverage • Creates a time-series record for earlier melanoma detection • Plugs directly into dermatology clinics Robotics is going to reshape healthcare.

English
2
3
13
2K
Ade Adamson, MD MPP
Ade Adamson, MD MPP@AdeAdamson·
@Dr_Foetus_13 I didn't even get into that in response to this post....but you are EXACTLY correct. This will just be more business for dermatologists cutting "cancers" out.
English
1
0
2
34
Dr Foetus
Dr Foetus@Dr_Foetus_13·
@AdeAdamson Pathologist here. Adamson’s work shows screening hasn’t reduced melanoma mortality, just inflated diagnoses. Now imagine scaling that problem with a robot scanning every patient. More data, same outcomes, more harm. Risk-stratified surveillance is the only defensible model.
English
1
0
0
43
Ade Adamson, MD MPP retweetledi
Paul Sax
Paul Sax@PaulSaxMD·
The problem with some of our best ideas in infectious diseases? They’re also the most frustrating. Six love-hates in ID (and bonus @IDSAInfo podcast). Link in reply ...
Paul Sax tweet media
English
9
10
54
11.1K
Ade Adamson, MD MPP retweetledi
Arjun (Raj) Manrai
Arjun (Raj) Manrai@arjunmanrai·
🧵1/ Our new study on AI and physician reasoning just came out in @ScienceMagazine. As co-senior author, I'm excited about our findings, and I do think AI will reshape medicine. But after seeing some of the discussions, I'm also worried about how our findings may be misinterpreted.
Arjun (Raj) Manrai tweet media
English
31
161
523
161K
Adam Gaffney
Adam Gaffney@awgaffney·
Deployment of AI tools in healthcare is getting ahead of the evidence. Here is a validation study of a *commercially available* radiology tool designed to detect misplaced nasogastric tubes, which can lead to disastrous outcomes. It missed 13% of them! ai.nejm.org/doi/full/10.10…
Adam Gaffney tweet media
English
3
5
29
4.7K
Ade Adamson, MD MPP
Ade Adamson, MD MPP@AdeAdamson·
@awgaffney Sadly we have a history of putting new shiny things ahead of evidence in medicine 😦. I'm certain this will be the case for AI.
English
1
0
1
165
Ade Adamson, MD MPP retweetledi
Healio Dermatology
Healio Dermatology@HealioDerm·
📈 The rising number of dermatology-specific advanced practice clinicians is associated with a growing share of dermatology drug spending, specifically in specialty medications. 🗣️ @AdeAdamson discussed with @GoHealio what this means. @JAMADerm vist.ly/4nnw8
English
0
1
2
197
Ade Adamson, MD MPP retweetledi
Timothée Olivier, MD
Timothée Olivier, MD@Timothee_MD·
If we talk about mortality, even with the increasing mortality rate for colorectal cancer, this cannot realistically be "felt" in clinic, the rise is impossible to be clinically "detectable" by a single physician. (see screenshot: colorectal : from 2.7 to 3.1/100 000/y over 30 years) When it comes to incidence and diagnoses, things are more complex. That's why we need works like the one published in @JAMAInternalMed, based on facts and numbers. @AdeAdamson and colleagues provided a balanced analysis which is often lacking in that space. Actually, I think their work is highly needed to be able to identify and focus on cancers where an actual increase in mortality is seen. See the nice discussion with @AdeAdamson here : theoncologyshot.com/p/are-fears-of…
Timothée Olivier, MD tweet media
English
1
2
5
681
Ade Adamson, MD MPP
Ade Adamson, MD MPP@AdeAdamson·
@GIMedOnc You are correct data tell the story and this is a 30 year story/trend we describe. Not sure how 5 years more will alter the trend unless something about diagnostic scrutiny decreases or a remarkable therapy is developed. See you then.
English
0
0
2
189
Nicholas Hornstein
Nicholas Hornstein@GIMedOnc·
Data tell the story, and none of us can predict with certainty where cancer incidence will go over the next decade. That said, I’ll save this in my folder of “probably wrong hot takes” and revisit it in five years (while working every day to to improve outcomes for these patients and help figure out a way to prevent this disease).
Ade Adamson, MD MPP@AdeAdamson

Searching for biologic causes for this epidemic is certainly going to be fruitless at best for most cancers, and at worst find some spurious association that needlessly scares the public.

English
1
1
16
3.6K
Ade Adamson, MD MPP
Ade Adamson, MD MPP@AdeAdamson·
@HannahRAbrams @AnilMakam "yet" is doing a lot of work here. Our study was over 30 years. How long of a latent period do you need to be convinced?! But as stated before, we don't know which ones progress, so we treat them all. More diagnostic scrutiny just makes this problem worse.
English
0
0
0
35
Hannah Abrams, MD
Hannah Abrams, MD@HannahRAbrams·
@AnilMakam @AdeAdamson Thanks for this - I guess we are coming to the same point, which is that there is a subset of aggressive, rapidly life threatening ca & another intercepted earlier where we don't necessarily know effect on mortality yet, and may never bc tx w/ curative intent, often successfully.
English
2
0
0
68
Anil Makam
Anil Makam@AnilMakam·
great thread by @HannahRAbrams! some thoughts story is figure 2, not figure 1 which is a smoothie of 8 cancers common feature, different than illnesses defined by symptoms, is that some grow/spread->illness & death, but others are "cancer" by pathology & regress/slowly grow
Hannah Abrams, MD@HannahRAbrams

@AnilMakam I really respect your thoughts and certainly agree some cancers are over-diagnosed. This paper & the response to it are a bit puzzling. They aggregate 8 cancers, chosen by relative⬆️incidence, rather than absolute. This ends up combining/comparing entities w/ diff explanations.

English
1
0
6
2.7K
Ade Adamson, MD MPP
Ade Adamson, MD MPP@AdeAdamson·
@AnilMakam @HannahRAbrams To add to this point we also don’t know whose individual lives are saved by screening either. All of this is a population effect. Hence the need to adjudicate this using a clinical trial.
English
0
0
1
54
Anil Makam
Anil Makam@AnilMakam·
@HannahRAbrams @AdeAdamson the population data cannot be applied to any given patient how would/could you know? unless we have better biomarkers/genetics that differentiate natural history
English
1
1
3
297
Ade Adamson, MD MPP
Ade Adamson, MD MPP@AdeAdamson·
@HannahRAbrams @AnilMakam The narrative is so far from “cancer is fake” right now. The pendulum is completely swung towards all of this is real and we need to find some environment toxin. We need to have a 4 day international conference and change screening guidelines. That’s where we are currently.
English
0
0
0
32
Hannah Abrams, MD
Hannah Abrams, MD@HannahRAbrams·
@AnilMakam @AdeAdamson This does make sense. This is a cohort from MSK, I should say so a group that may have had more access to f/u of sx. I think another big part of the desire to make sure the narrative doesn't become "AYA cancer is fake" is having seen many EOCRC pts blown off & dx late.
English
2
0
1
104

Keşfet

@DrJoelGelfand @EthicsUnwrapped @YounisJoseph @Dr_Foetus_13 @IDSAInfo @ScienceMagazine @awgaffney @GoHealio